When it comes to developing new drugs, one of the most time-consuming and complex pieces of the puzzle is the task of compiling all of the data collected throughout the clinical development process to ...

As pharmaceutical manufacturing grows increasingly complex, Merck KGaA wants to ramp up its development capabilities for clinical trial compounds. The German life sciences company got one step closer ...

Less than a week after acquiring biotechs on either side of the Atlantic, Ginkgo Bioworks has scored a deal with Merck to bolster the pharma giant's active pharmaceutical ingredient manufacturing.

Strategic collaboration brings together Mayo Clinic's extensive clinical insights, genomic data and Platform architecture with Merck (MRK)'s artificial intelligence (AI) and machine learning (ML) ...

Dec 16 (Reuters) - Merck (MRK.N), opens new tab said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials. The pharmaceutical giant's ...

€250 million investment reflects Merck’s commitment to speed up availability of new medicines to patients in need Biotech Development Center confirms Switzerland’s position as Merck’s prime hub for ...